Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Post-market Randomized Controlled Trial (RCT) to Demonstrate Clinical Utility of an Amniotic Membrane Allograft in Diabetic Foot Ulcer (DFU) Wound Management

NCT06420245 is registered in ClinicalTrials.gov with Legacy Medical Consultants as lead sponsor.

NCT NCT06420245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06420245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Post-market Randomized Controlled Trial (RCT) to Demonstrate Clinical Utility of an Amniotic Membrane Allograft in Diabetic Foot Ulcer (DFU) Wound Management
Lead sponsor
Legacy Medical Consultants
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 30, 2025
Completion date
July 31, 2027
Enrollment
240 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer